D S Greene - JoVE Visualize

Showing results (21-30 of 51) with videos related to

Pageof 6

Sort By:

Journal of Clinical Pharmacology|March 20, 1998

The effects of age and gender on the single dose pharmacokinetics of avitriptan administered to healthy volunteersP H Marathe, D S Greene, G D Kollia, et al.

Clinical Pharmacology and Therapeutics|April 29, 1998

A pharmacokinetic interaction study of avitriptan and propranololP H Marathe, D S Greene, G D Kollia, et al.

Clinical Pharmacology and Therapeutics|March 1, 1986

The effect of age on ranitidine pharmacokineticsD S Greene, P L Szego, J A Anslow, et al.

European Journal of Clinical Pharmacology|January 1, 1995

Steady-state pharmacokinetics of nefazodone in subjects with normal and impaired renal functionR H Barbhaiya, M E Brady, U A Shukla, et al.

Journal of Clinical Psychopharmacology|October 1, 1995

Coadministration of nefazodone and benzodiazepines: II. A pharmacokinetic interaction study with triazolamR H Barbhaiya, U A Shukla, P D Kroboth, et al.

British Journal of Clinical Pharmacology|January 1, 1996

Comparison of the steady-state pharmacokinetics of nefazodone after administration of 200 mg twice daily or 400 mg once daily in the morning or eveningP H Marathe, J S Lee, D S Greene, et al.

Biopharmaceutics & Drug Disposition|May 7, 1998

Assessment of effect of food, gender, and intra-subject variability in the pharmacokinetics of avitriptanP H Marathe, D S Greene, J S Lee, et al.

British Journal of Clinical Pharmacology|December 23, 1998

The effects of age and gender on the pharmacokinetics of irbesartanN N Vachharajani, W C Shyu, R A Smith, et al.

Biopharmaceutics & Drug Disposition|September 16, 1998

Evaluation of the effect of food on the pharmacokinetics of avitriptanP H Marathe, D S Greene, G D Kollia, et al.

British Journal of Clinical Pharmacology|December 1, 1995

Lack of an effect of nefazodone on the pharmacokinetics and pharmacodynamics of theophylline during concurrent administration in patients with chronic obstructive pulmonary diseaseR C Dockens, D Rapoport, D Roberts, et al.

Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:

Pageof 6

Journal of Clinical Pharmacology|March 20, 1998

The effects of age and gender on the single dose pharmacokinetics of avitriptan administered to healthy volunteersP H Marathe, D S Greene, G D Kollia, et al.

Clinical Pharmacology and Therapeutics|April 29, 1998

A pharmacokinetic interaction study of avitriptan and propranololP H Marathe, D S Greene, G D Kollia, et al.

Clinical Pharmacology and Therapeutics|March 1, 1986

The effect of age on ranitidine pharmacokineticsD S Greene, P L Szego, J A Anslow, et al.

European Journal of Clinical Pharmacology|January 1, 1995

Steady-state pharmacokinetics of nefazodone in subjects with normal and impaired renal functionR H Barbhaiya, M E Brady, U A Shukla, et al.

Journal of Clinical Psychopharmacology|October 1, 1995

Coadministration of nefazodone and benzodiazepines: II. A pharmacokinetic interaction study with triazolamR H Barbhaiya, U A Shukla, P D Kroboth, et al.

British Journal of Clinical Pharmacology|January 1, 1996

Comparison of the steady-state pharmacokinetics of nefazodone after administration of 200 mg twice daily or 400 mg once daily in the morning or eveningP H Marathe, J S Lee, D S Greene, et al.

Biopharmaceutics & Drug Disposition|May 7, 1998

Assessment of effect of food, gender, and intra-subject variability in the pharmacokinetics of avitriptanP H Marathe, D S Greene, J S Lee, et al.

British Journal of Clinical Pharmacology|December 23, 1998

The effects of age and gender on the pharmacokinetics of irbesartanN N Vachharajani, W C Shyu, R A Smith, et al.

Biopharmaceutics & Drug Disposition|September 16, 1998

Evaluation of the effect of food on the pharmacokinetics of avitriptanP H Marathe, D S Greene, G D Kollia, et al.

British Journal of Clinical Pharmacology|December 1, 1995

Lack of an effect of nefazodone on the pharmacokinetics and pharmacodynamics of theophylline during concurrent administration in patients with chronic obstructive pulmonary diseaseR C Dockens, D Rapoport, D Roberts, et al.

Pageof 6